|
XRCC4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.316400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.168800E-01 |
| Normal-vs-Stage2 |
2.843700E-02 |
| Normal-vs-Stage3 |
6.842800E-01 |
| Normal-vs-Stage4 |
3.656200E-01 |
| Stage1-vs-Stage2 |
8.158500E-02 |
| Stage1-vs-Stage3 |
5.565800E-01 |
| Stage1-vs-Stage4 |
7.082200E-01 |
| Stage2-vs-Stage3 |
3.113700E-02 |
| Stage2-vs-Stage4 |
3.586800E-01 |
| Stage3-vs-Stage4 |
4.990200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.413800E-01 |
| Normal-vs-AfricanAmerican |
6.881000E-01 |
| Normal-vs-Asian |
7.115000E-01 |
| Caucasian-vs-AfricanAmerican |
3.518400E-01 |
| Caucasian-vs-Asian |
7.594400E-01 |
| AfricanAmerican-vs-Asian |
5.102200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.850400E-01 |
| Normal-vs-Female |
3.771800E-01 |
| Male-vs-Female |
7.339800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.337200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.618220E-01 |
| Normal-vs-Age(61-80Yrs) |
1.072960E-01 |
| Normal-vs-Age(81-100Yrs) |
4.969600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.240440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.357700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.868000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.828200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.852770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.229200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.791200E-01 |
| Classical-VS-Follicular |
6.88338275267597E-15 |
| Classical-VS-Other |
6.304800E-01 |
| Classical-VS-Normal |
7.987400E-01 |
| Tall-VS-Follicular |
1.98669999995627E-06 |
| Tall-VS-Other |
7.061000E-01 |
| Tall-VS-Normal |
9.617600E-01 |
| Follicular-VS-Other |
1.695760E-01 |
| Follicular-VS-Normal |
2.86629999735055E-08 |
| Other-VS-Normal |
6.935200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.922200E-02 |
| Normal-vs-N1 |
6.766400E-01 |
| N0-vs-N1 |
1.640630E-01 |
|
|
